Die Merkblätter können kostenlos in verschiedenen Sprachen (Deutsch, Englisch, Albanisch, Arabisch, Farsi, Paschtunisch, Kurdisch, Serbisch, Somali, Urdu und Tigrinya) heruntergeladen werden auf der Webseite
http://www.lgl.bayern.de/gesundheit/infektionsschutz/asylbewerber_gesundheit/index.htm
u...nter dem Punkt "Asylbewerber und Gesundheit"
more
Information leaflets can be downloaded free of charge from http://www.lgl.bayern.de/gesundheit/infektionsschutz/asylbewerber_gesundheit/index.htm under the section "Asylbewerber und Gesundheit". Also available in following language versions: Arabic, Bulgarian, German, French, Greek, Italian, Croati...an, Polish, Romanian, Russian, Serbian (kyrillic or latin), Spanish, Turkish, Hungarian.
more
DOI:https://doi.org/10.1016/S2213-2600(20)30316-7
The Lancet Respiratory Medicine
Die folgenden Empfehlungen sind als Unterstützung und Anregung gedacht, die stets individüll angepasst undabgewandeltwerdenkönnen.SiebasierenaufunseremWissensstandvom18.03.2020.
Prinzipiell werden Atemschutzmasken seit Jahren als Einwegprodukte in Verkehr gebracht und nach Benutzung nicht aufbereitet. Der im Rahmen der COVID-19-Pandemie auftretende Mangel an Atemschutzmasken zwingt gegenwärtig viele Gesundheitseinrichtungen, diese Artikel mehrfach zu verwenden.
Ethical perspectives on a future vaccination program against COVID-19 in Germany
Patienteninformation - Englisch
Many critical questions remain about the effectiveness of COVID-19 vaccines in real-world settings. These questions can only be answered in post-introduction vaccine effectiveness studies.This guidance document outlines an approach to leverage existing surveillance systems for Severe Acute Respirato...ry Infection (SARI) to estimate COVID-19 vaccine effectiveness (VE) in preventing SARI associated with laboratory-confirmed SARS-CoV-2 using existing SARI surveillance systems. The approach uses the test-negative design to evaluate VE; cases are SARI patients who tested positive for SARS-CoV-2, and controls are SARI patients who tested negative for SARS-CoV-2.
more
This handbook follows a comprehensive approach to health system strengthening at borders in order to support IHR national focal points and other national agencies in developing and implementing evidence-based action plans for IHR capacity development at ground crossings. The approach includes the mo...vement of travellers and baggage, cargo, containers, conveyances, goods and postal parcels across ground crossings, as well as the interaction with adjacent border communities. Other factors can be considered, if needed, throughout the risk assessment.
more
Research Article
Karo et al. BMC Infectious Diseases 2014, 14:148 http://www.biomedcentral.com/1471-2334/14/148
The report reveals that good IPC programmes can reduce health care infections by 70 %. oday, out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries will acquire at least one health care-associated infection (HAI)... during their hospital stay. On average, 1 in every 10 affected patients will die from their HAI.
People in intensive care and newborns are particularly at risk. And the report reveals that approximately one in four hospital-treated sepsis cases and almost half of all cases of sepsis with organ dysfunction treated in adult intensive-care units are health care-associated.
more
Laboratory Biossafety Manual
DOI 10.15252/emmm.201404792 |Published online 30.12.2014
EMBO Molecular Medicine(2014)emmm.201404792
Informationen über Krankheitserreger beim Menschen
Bürgerinformation
Recommendations and Reports: Stand: April 2016 | Seite 1 - 2
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...e the genetic mechanism has been established.
The current goal of elimination of HAT as a public health problem by 2020 may be undermined by the emergence and spread of resistance to current or new drugs.
Insights into potential resistance mechanisms for current and new drugs will facilitate predictions of the likelihood of resistance and will also facilitate rational approaches to minimizing, monitoring, and tackling the future emergence of resistance.
more